ELOCTATE 1000
Land: Ísrael
Tungumál: enska
Heimild: Ministry of Health
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
COAGULATION FACTOR VIII
Fáanlegur frá:
SANOFI - AVENTIS ISRAEL LTD
ATC númer:
B02BD05
Lyfjaform:
POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Samsetning:
COAGULATION FACTOR VIII 1000 IU
Stjórnsýsluleið:
I.V
Gerð lyfseðils:
Required
Framleitt af:
BIOGEN IDEC LIMITED , UK
Lækningarsvæði:
COAGULATION FACTOR VII
Ábendingar:
ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.
Leyfisdagur:
2017-01-09
